A promising target to treat asthma

University of Iowa team finds enzyme in airway lining cells could hold key for asthma sufferers

2013-07-25

(Press-News.org) An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms. The finding could lead to the development of a drug that would target the CaMKII enzyme, the researchers say.

Asthma affects billions of people worldwide. In the United States, 8.5 percent of the population has asthma, which causes 3,000 deaths and more than $56 billion annually in medical and lost work costs, according to the federal Centers for Disease Control and Prevention. Despite its toll on health and productivity, treatment options remain confined to steroids, which have harmful, even life-threatening, side effects for those with severe cases.

Current treatments don't work well, noted Mark Anderson, professor and chair in internal medicine at the UI and a co-corresponding author on the paper, published July 24 in the journal Science Translational Medicine.

"It's a kind of an epidemic without a clear, therapeutic option," Anderson says. "The take-home message is that inhibiting CaMKII appears to be an effective anti-oxidant strategy for treating allergic asthma."

Anderson and co-corresponding author Isabella Grumbach knew from previous work that the CaMKII enzyme played a role in the oxidation of heart muscle cells, which can lead to heart disease and heart attacks. The scientists surmised the same enzyme may affect oxidation in the respiratory system as well.

The team first tested the enzyme in airway muscle cells, but to little effect. They then tried to block the enzyme in the airway lining (epithelial) cells. They noticed that mice with the blocked enzyme had less oxidized CaMKII, no airway muscle constriction and no asthma symptoms. Similarly, mice without the blocked enzyme showed high "oxidative stress," meaning lots of oxidized enzymes in the epithelial cells, a constricted airway and asthma symptoms.

"[The study] suggests that these airway lining cells are really important for asthma, and they're important because of the oxidative properties of CaMKII," says Anderson, whose primary appointment is in the Carver College of Medicine. "This is completely new and could meet a hunger for new asthma treatments. Here may be a new pathway to treat asthma."

"Ten years ago, not much was known about what CaMKII does outside of nerve cells and muscle cells in the heart," says Grumbach, associate professor in internal medicine at the UI. "My lab has worked on investigating its function mainly in blood vessels with the long-term goal to use blockers of CaMKII to treat common diseases. We are constantly finding that CaMKII is interesting and important."

The researchers also took tissue samples from the airways of patients with asthma. True to their hypothesis, they found more oxidized enzymes in those patients than in healthy individuals. Taking a step further, the team found that mild asthma patients who inhaled an allergen had a spike in oxidized CaMKII in the epithelial cells just a day later.

"We have this very compelling association," Anderson says, adding that more studies in patients are needed to validate the approach.

The researchers also plan to investigate inhaled drugs that could block the oxidation of theCaMKII enzyme, for treating heart disease and asthma. Anderson has a patent and is involved in a company, Allosteros Therapeutics, which is seeking to develop such a drug.

INFORMATION:

The paper's first author is Philip Sanders, a former postdoctoral student in Grumbach's lab, helped design the study and analyzed much of the data. Contributing authors from the UI include Olha Koval, Omar Jaffer, Anand Prasad, Thomas Businga, Jason Scott, Elizabeth Luczak, David Dickey, Francis Miller, Jr., Megan Dibbern, Joseph Zabner, Joel Kline, Chantal Allamargot, Alicia Olivier, David Meyerholz, Brett Wagner, Garry Buettner and Marshall Pope. Other contributing authors are Patrick Hayden from MatTek Corporation; Alfred Robison from the Mount Sinai School of Medicine in New York; Danny Winder, Timothy Blackwell and Ryszard Dworski from Vanderbilt University; Hans Michael Haitchi, David Sammut and Peter Howarth from the University of Southampton, United Kingdom; and Peter Mohler from Ohio State University.

The National Institutes of Health (grant numbers: K23 HL080030 02 and M01 RR-00095), the American Asthma Foundation and the Sandler Program for Asthma Research funded the work.

ELSE PRESS RELEASES FROM THIS DATE:

More central line infections seen in children with cancer once they leave the hospital

2013-07-25

Pediatric cancer patients whose central lines are used to treat them at home develop three times as many dangerous bloodstream infections from their devices than their hospitalized counterparts, according to the results of a new Johns Hopkins Children's Center study. Findings of the research, reported online July 23 in the journal Pediatric Blood & Cancer, provide valuable insight into the safety of central line uses outside the hospital and underscore the need to carefully evaluate the benefits and risk of sending a child home with one, the investigators say. Furthermore, ...

Are North Atlantic right whales mating in the Gulf of Maine?

2013-07-25

Using data obtained during six years of regular aerial surveys and genetics data collected by a consortium of research groups, scientists have strengthened evidence pointing to the central Gulf of Maine as a mating ground for North Atlantic right whales, according to a study recently published online in the journal Endangered Species Research. The North Atlantic right whale (Eubalaena glacialis) is one of the most endangered marine mammal species in the world and has been intensively studied for decades. Much has been learned about its habitat, behavior, and population ...

Newly discovered marine viruses offer glimpse into untapped biodiversity

2013-07-25

Researchers of the University of Arizona's Tucson Marine Phage Lab have discovered a dozen new types of unknown viruses that infect different strains of marine bacteria. Bacteriophages – viruses that prey on bacteria – are less familiar to most people than their flu- or cold-causing cousins, but they control processes of global importance. For example, they determine how much oxygen goes from the oceans into the atmosphere in exchange for carbon dioxide, they influence climate patterns across the Earth and they alter the assemblages of microorganisms competing in the ...

New genetic cause of pulmonary hypertension identified

2013-07-25

NEW YORK, NY (July 25, 2013) — Columbia University Medical Center (CUMC) scientists have identified new genetic mutations that can cause pulmonary arterial hypertension (PAH), a rare fatal disease characterized by high blood pressure in the lungs. The mutations, found in the gene KCNK3, appear to affect potassium channels in the pulmonary artery, a mechanism not previously linked to the condition. Cell culture studies showed that the mutations' effects could be reversed with a drug compound known as a phospholipase inhibitor. The study was published today in the online ...

Boreal forests in Alaska becoming more flammable

2013-07-25

A 2,000-square-kilometer zone in the Yukon Flats of interior Alaska--one of the most flammable high-latitude regions of the world--has seen a dramatic increase in both the frequency and severity of fires in recent decades, according to research funded by the National Science Foundation (NSF). Wildfire activity in this area is higher than at any other time in the past 10,000 years, the researchers report. The research, funded by NSF's Division of Polar Programs, adds to the evidence that relatively frequent and powerful fires are converting the conifer-rich boreal ...

New Notre Dame study proposes changes in New Orleans area levee systems

2013-07-25

Less may mean more when it comes to the levee systems designed to protect New Orleans from hurricanes. That's the conclusion of a new study by a team of University of Notre Dame researchers led by Joannes Westerink, co-developer of the authoritative computer model for storm surge used by the U.S. Army Corps of Engineers, the Federal Emergency Management Agency (FEMA) and the state of Louisiana to determine water levels due to hurricane surge and to design levee heights and alignments. The lower Mississippi River south of New Orleans protrudes into the Gulf of Mexico ...

Potential cause of Parkinson's disease points to new therapeutic strategy

2013-07-25

LA JOLLA, CA – July 24, 2013 – Biologists at The Scripps Research Institute (TSRI) have made a significant discovery that could lead to a new therapeutic strategy for Parkinson's disease. The findings, recently published online ahead of print in the journal Molecular and Cell Biology, focus on an enzyme known as parkin, whose absence causes an early-onset form of Parkinson's disease. Precisely how the loss of this enzyme leads to the deaths of neurons has been unclear. But the TSRI researchers showed that parkin's loss sharply reduces the level of another protein that ...

Seeing photosynthesis from space: NASA scientists use satellites to measure plant health

2013-07-25

NASA scientists have established a new way to use satellites to measure what's occurring inside plants at a cellular level. Plants grow and thrive through photosynthesis, a process that converts sunlight into energy. During photosynthesis, plants emit what is called fluorescence – light invisible to the naked eye but detectable by satellites orbiting hundreds of miles above Earth. NASA scientists have now established a method to turn this satellite data into global maps of the subtle phenomenon in more detail than ever before. Healthy plants use the energy from sunlight ...

Obese kidney failure patients receive survival benefit from transplantation

2013-07-25

Most obese individuals with kidney failure can prolong their lives by receiving a kidney transplant, although this survival benefit is lower in severely obese individuals. That's the conclusion of a new study published in the American Journal of Transplantation. The findings will hopefully decrease differences in access to transplantation for obese patients. Obesity is increasing in patients with kidney failure. In some studies, obese kidney failure patients who are on dialysis have a lower risk of dying prematurely than non-obese patients. In contrast, obese kidney ...

Flow restrictors may reduce young children's accidental ingestion of liquid medications

2013-07-25

Cincinnati, OH -- In the US, child-resistant packaging for most medications has contributed to the prevention of thousands of pediatric deaths. Nevertheless, over 500,000 calls are made to poison control centers each year after accidental ingestion of medications by young children, and the number of emergency department visits for unsupervised medication ingestions is rising. In a new study scheduled for publication in The Journal of Pediatrics, researchers studied whether adding flow restrictors to bottles can limit the amount of liquid medication a child could access ...

A promising target to treat asthma

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: